Today's biotech news includes a Terns drug showing strong early efficacy data, a new CEO at DNA sequencing firm Oxford Nanopore, and more.
Readout Newsletter
Today's biotech news includes a Terns drug showing strong early efficacy data, a new CEO at DNA sequencing firm Oxford Nanopore, and more.